Clinical Ink Adds Executives

Clinical Ink, a global clinical trial technology company, has appointed CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso. All three positions are newly created to help manage the company’s eCOA, ePRO+, DDC, and eConsent platform.

“Clinical Ink pioneered the development of decentralized trials (eSource) long before the label even existed and we are responding to the tremendous growth opportunities ahead,” said Clinical Ink CEO, Ed Seguine. “This industry is plagued with visionary talk that so often lacks substance and comes up short in real-life. Adding these experienced industry veterans builds on the disciplined execution mindset we have cultivated over the years. These leaders bring great insight, expertise, and vision to our confident, reliable delivery of results in the most complex and demanding therapeutic areas.”

Clinical Ink’s Lunexis platform collects clinical trial data from patients and clinicians, at home and on-site. Lunexis began as a way to transition sites from EDC to DDC (eSource) and to enable easier patient participation at home with BYOD ePRO+. It now offers “Build Your Own Study” capabilities for sponsors and CROs to have greater control over study design and execution.

Christopher Crucitti is a 20+ year life sciences and clinical services/technology executive. Prior to joining Clinical Ink, Chris most recently held the role of Chief Commercial Officer at Signant Health, where he led the commercial functions and go-to-market strategy.

Prior to joining the company, Brian held a variety of leadership roles at GE for 16 years. Brian began his career in GE’s Operations Leadership Program, which led to multiple roles within GE Capital prior to his transition to GE Healthcare, where he served in operational, commercial, and general management leadership positions in the U.S. and Canada.

Bill Barrasso brings a deep understanding of clinical trial processes and regulatory guidance required for successful study execution. Bill established the eCOA delivery services team at Parexel after leading eCOA services organizations at both ERT and PHT Corporation.